Recognition of Individual Risks by Analysis of Subcellular Imaging Insights into Chromium Picolinate Therapy in Pre/Diabetes Care, Search into Its Safety and Opinion Controversy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-94-007-5971-8_14
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Global Figures Argue in Favour of Preventive Measures and Personalised Treatment to Optimise Inadequate Diabetes Care

  2013cited by this paper
• Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice.

  2012cited by this paper
• Molecular and cellular mechanisms of hexavalent chromium-induced lung cancer: an updated perspective.

  2012cited by this paper
• Time for new guidelines in advanced healthcare: the mission of The EPMA Journal to promote an integrative view in predictive, preventive and personalized medicine

  2012cited by this paper
• Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelines.

  2011cited by this paper
• Promoting predictive, preventive and personalised medicine: European event of global importance

  2011cited by this paper
• A Pilot Study of Chromium Picolinate for Weight Loss

  2010cited by this paper
• Common origin but individual outcomes: time for new guidelines in personalized healthcare.

  2010cited by this paper
• Inadequate diabetic care: global figures cry for preventive measures and personalized treatment

  2010cited by this paper
• Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice.

  2010cited by this paper
• Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine

  2010cited by this paper
• Autoschizis of T-cells is induced by the nutritional supplement, Cr(III)picolinate.

  2010cited by this paper
• Advanced Diabetes care: three levels of prediction, prevention & personalized treatment.

  2010cited by this paper
• Chronic toxicity and carcinogenicity studies of chromium picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years.

  2009cited by this paper
• Chromium picolinate induced apoptosis of lymphocytes and the signaling mechanisms thereof.

  2009cited by this paper
• Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults

  2009cited by this paper
• Effect of chromium supplementation on the diabetes induced-oxidative stress in liver and brain of adult rats

  2009cited by this paper
• Diabetic complications: Pathogenic mechanisms and prognostic indicators

  2009cited by this paper
• Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer.

  2008cited by this paper
• Study of Oxidative Damage in Growing–Finishing Pigs with Continuous Excess Dietary Chromium Picolinate Intake

  2008cited by this paper
• Clinical Proteomics in Application to Predictive Diagnostics and Personalized Treatment of Diabetic Patients

  2008cited by this paper
• Comparison of the potential for developmental toxicity of prenatal exposure to two dietary chromium supplements, chromium picolinate and [Cr3O(O2CCH2CH3)(6(H2O)3]+, in mice.

  2008cited by this paper
• Supplements and the endocrine system in athletes.

  2008cited by this paper
• Transmission Electron Microscopy

  2008cited by this paper
• Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro.

  2007cited by this paper
• Molecular analysis of hprt mutations induced by chromium picolinate in CHO AA8 cells.

  2006cited by this paper
• Acute Tubular Necrosis Associated with Chromium Picolinate–Containing Dietary Supplement

  2006cited by this paper
• Nutritional supplement chromium picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster.

  2006cited by this paper
• Exposure of pregnant mice to chromium picolinate results in skeletal defects in their offspring.

  2006cited by this paper
• Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration.

  2006cited by this paper
• Chromium-picolinate induced ocular changes: Protective role of ascorbic acid.

  2006cited by this paper
• Molecular imaging system for possible prediction of active retinopathy in patients with Diabetes mellitus

  2005cited by this paper
• Death by tanning — a case of fatal basic chromium sulphate poisoning

  2005cited by this paper
• Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate.

  2005cited by this paper
• The Potential Value and Toxicity of Chromium Picolinate as a Nutritional Supplement, Weight Loss Agent and Muscle Development Agent

  2003cited by this paper
• DNA damage and expression of checkpoint genes p21WAF1/CIP1 and 14-3-3 σ in taurine-deficient cardiomyocytes

  2003cited by this paper
• Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster

  2003cited by this paper
• The safety and efficacy of high-dose chromium.

  2002cited by this paper
• Ultrastructural damage in chromium picolinate-treated cells: a TEM study

  2002cited by this paper
• Cytotoxicity and oxidative mechanisms of different forms of chromium.

  2002cited by this paper
• Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells.

  2002cited by this paper
• Release of Cr(III) from Cr(III) picolinate upon metabolic activation.

  2001cited by this paper
• Elucidating a biological role for chromium at a molecular level.

  2000cited by this paper
• Acute generalized exanthematous pustulosis induced by chromium picolinate.

  1999cited by this paper
• The nutritional supplement chromium(III) tris(picolinate) cleaves DNA.

  1999cited by this paper
• Chromium Picolinate Toxicity

  1998cited by this paper
• Chromium deficiency after long-term total parenteral nutrition

  1986cited by this paper
• Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition.

  1977cited by this paper
• Modern Nutrition in Health and Disease

  1965cited by this paper

• Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes

  2014cites this paper
• Personalized Medicine and Patient Modelling

  2013cites this paper